South African scientists identified a new version of the coronavirus this week that they say is behind a recent spike in COVID-19 infections in the country's most populous province. In a statement on ...
Moderna’s bivalent COVID-19 vaccine has bettered the antibody response of Spikevax against omicron when given as a booster, offering encouragement to the biotech as it races toward phase 2/3 data that ...
Beta-vax: Sanofi, GSK hail phase 3 omicron win to throw down gauntlet in COVID-19 vaccine format war
After lagging the leaders in the original COVID-19 vaccine race, Sanofi and GSK have now claimed a first in the push to protect people from omicron. The partners hailed the first successful efficacy ...
Drugmakers are racing to develop new vaccines intended to target the omicron variant, a coronavirus strain that has mutations that suggest it could evade immunity provided by vaccination or natural ...
(Reuters) - Moderna Inc on Tuesday said a COVID-19 booster designed to target the Beta variant as well as the original coronavirus generated a better immune response against a number of virus variants ...
People hospitalized with the omicron variant of COVID-19 tend to be in the hospital a shorter period of time, have less need for supplemental oxygen and generally don't progress as frequently to ...
South African scientists identified a new version of the coronavirus this week that they say is behind a recent spike in COVID-19 infections in the country's most populous province. In a statement on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback